Online ISSN: 2515-8260

Keywords : Death rate


Statistical Analysis on Novel Corona Virus: COVID-19

Vimal Kumar M N; JAYA R; Rubesh C M; Aakash Ram S

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 95-103

A novel coronavirus, 2019nCoV is identified as the root cause for such a deadly outbreak causing respiratory illness. Due to its widespread impact on the global community, stringent measures were implemented to reduce the effect of the outbreak; self-precautionary measures like using face-masks, hand hygiene, and self-quarantine; environmental measures were insisted to follow and also surface cleaning and community measures to prevent the widespread. The pandemic evolved in China towards the end of 2019 and COVID 19 started to spread all over the globe like a typical wildfire capturing over 190 countries. It grows in a human body with common symptoms like common cold leading to respiratory problems and at times even death. The virus grows exponentially. So, based on the symptoms and the activity of the virus various measures have been implemented. The death rate peaked in the USA and Iran at the end of March and due to comorbidities and many medications has helped in cutting down the numbers. The rate of spread did not shoot up in countries like India due to preventive and cautious care and also due to reduced human contact from the countries with incidence or spread of the vector to other countries.

COVID-19: ITS INCIDENCE AND RECOVERY AMONG GLOBAL POPULATION - A REVIEW

Soorya Ganesh; Dr. Lavanya Prathap; Dr. V.Vishnu Priya; Dr. Preetha S

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 285-291

Background:
Coronavirus disease 2019 is an infectious disease caused by severe acute respiratory syndrome . The
disease was first identified on december 2019 in Wuhan,the capital of China Hubei province and has since
spread globally resulting in the ongoing 2019-2020 coronavirus pandemic. Most recently,the middle east
respiratory syndrome coronavirus(MERS-COV)was first identified in Saudi Arabia in 2012. In a timeline
that reaches the present day which is an epidemic of cases with unexplained low respiratory infection
detected in Wuhan,the largest metropolitan area in China’s Hubei province which was first reported to the
WHO country office in China,on dec 31,2019.
Aim:To review the incidence and recovery of COVID-19 pandemic outbreak among the global
population.
Materials and methods: This is a literature review conducted using article sources from databases-
Scopus and PubMed from september 2019 to April 2020. The articles are screened for data extraction and
the characteristics of studies are tabulated. The collected data is analysed and the results are reported.
Results and Conclusion: The findings of the review suggests that the recovery cases are less compared
to active cases,because it is so contagious which represents the average number of people to which a single
infected person transmits the virus is relatively high.

ALLOGENEIC BONE MARROW TRANSPLANTATION IN MULTIPLE MYELOMA - A REVIEW OF LITERATURE

Deepthi Sogasu; Brundha MP; Smiline Girija AS

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 1, Pages 421-430

Multiple myeloma is a hematological malignancy of the plasma cells with evidence of bone marrow infiltration. It is accompanied with extramedullary plasmacytomas. There are a variety of possible treatment options, but this review focuses on allogeneic bone marrow transplantation for the treatment of multiple myeloma. Allogeneic bone marrow transplant is commonly known as stem cell transplantation. From the review, the results suggest that this can be used as a treatment option for fit young individuals as compared to older individuals. It also shows better results during the early stages relative to the later stages with poor prognosis. In conclusion, allogeneic bone marrow transplant can help treat multiple myeloma, but it depends on factors such as age, stage of cancer, fitness of the individual.